A Phase 1, Single-Blind, Randomized, Placebo Controlled, Parallel-Group, Multiple-Dose-Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of Emodepside (BAY 44-4400) After Oral Dosing in Healthy Male Subjects
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Emodepside (Primary)
- Indications Filariasis; Onchocerciasis
- Focus Adverse reactions; First in man
- 24 Mar 2021 Results published in the British Journal of Clinical Pharmacology
- 28 Feb 2019 Status changed from recruiting to completed.
- 20 Jun 2018 Planned End Date changed from 2 Jul 2018 to 1 Oct 2018.